PolyPid Financial Statements From 2010 to 2026

PYPD Stock

USD 4.71 0.01 0.21%

PolyPid's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing PolyPid's valuation are provided below:

Market Capitalization

79.8 M

Earnings Share

(2.81)

There are over one hundred nineteen available trending fundamental ratios for PolyPid, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of PolyPid's recent performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Enterprise Value is expected to grow to about 20.4 M, whereas Market Cap is forecasted to decline to about 18.5 M.

Check PolyPid financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PolyPid's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2 M, Interest Expense of 1.7 M or Selling General Administrative of 5.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.21. PolyPid financial statements analysis is a perfect complement when working with PolyPid Valuation or Volatility modules.

Build AI portfolio with PolyPid Stock

Check out the analysis of PolyPid Correlation against competitors.

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

PolyPid Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Total Assets

26 M

29 M

20.2 M

Slightly volatile

Other Current Liabilities

1.8 M

3 M

1.5 M

Slightly volatile

Total Current Liabilities

15.3 M

14.6 M

5 M

Slightly volatile

Property Plant And Equipment Net

5.6 M

9.6 M

4.6 M

Slightly volatile

Accounts Payable

1.4 M

2.8 M

1.2 M

Slightly volatile

Cash

18.9 M

18 M

6.7 M

Slightly volatile

Non Current Assets Total

8 M

9.9 M

6.3 M

Slightly volatile

Non Currrent Assets Other

302.6 K

318.6 K

1.6 M

Pretty Stable

Other Assets

108.2 K

113.8 K

1.5 M

Pretty Stable

Cash And Short Term Investments

16.9 M

18 M

13.1 M

Slightly volatile

Net Receivables

359.8 K

342.7 K

144.4 K

Slightly volatile

Common Stock Total Equity

95.7 K

148.3 K

103.7 K

Slightly volatile

Common Stock Shares Outstanding

7.1 M

6.8 M

1.9 M

Slightly volatile

Liabilities And Stockholders Equity

26 M

29 M

20.2 M

Slightly volatile

Non Current Liabilities Total

4.2 M

4.4 M

18.7 M

Very volatile

Other Current Assets

960.6 K

1.1 M

763.2 K

Slightly volatile

Total Liabilities

23.3 M

15.8 M

23.7 M

Very volatile

Total Current Assets

18 M

19.1 M

14 M

Slightly volatile

Common Stock

109.2 K

149.5 K

104.9 K

Slightly volatile

Property Plant Equipment

14.1 M

13.4 M

5.6 M

Slightly volatile

Short and Long Term Debt Total

9.7 M

11.1 M

8.2 M

Slightly volatile

Long Term Debt

542.1 K

570.6 K

6 M

Very volatile

Long Term Debt Total

57.2 M

54.5 M

29.3 M

Slightly volatile

Property Plant And Equipment Gross

11.6 M

20.5 M

7.8 M

Slightly volatile

Other Liabilities

3.4 M

3.3 M

1.4 M

Slightly volatile

Non Current Liabilities Other

291.3 K

455.4 K

274.5 K

Slightly volatile

Deferred Long Term Liabilities

870.4 K

979.2 K

1.1 M

Slightly volatile

Current Deferred Revenue

3.1 M

2.9 M

974.8 K

Slightly volatile

Short and Long Term Debt

5.4 M

7.8 M

4.5 M

Slightly volatile

Short Term Debt

6.3 M

8.9 M

5.4 M

Slightly volatile

PolyPid Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation And Amortization

2 M

1.9 M

780.9 K

Slightly volatile

Selling General Administrative

5.1 M

4.9 M

4.1 M

Slightly volatile

Other Operating Expenses

21.4 M

32.2 M

17.6 M

Slightly volatile

Research Development

15.4 M

26.2 M

12.8 M

Slightly volatile

Total Operating Expenses

21.3 M

32.2 M

17.6 M

Slightly volatile

Interest Income

331.4 K

493.2 K

749.4 K

Slightly volatile

Cost Of Revenue

1 M

1.9 M

735.2 K

Slightly volatile

Reconciled Depreciation

1.2 M

1.9 M

786.8 K

Slightly volatile

Selling And Marketing Expenses

1.7 M

1.1 M

Slightly volatile

PolyPid Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Sale Purchase Of Stock

45.5 M

43.3 M

22.5 M

Slightly volatile

Begin Period Cash Flow

5.6 M

6.5 M

4.4 M

Slightly volatile

Capital Expenditures

83 K

87.4 K

792 K

Pretty Stable

Total Cash From Financing Activities

20.4 M

37.3 M

17.1 M

Slightly volatile

Stock Based Compensation

2.7 M

3.2 M

1.9 M

Slightly volatile

Issuance Of Capital Stock

18.6 M

32.3 M

17 M

Slightly volatile

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Payables Turnover

1.43

1.36

0.6371

Slightly volatile

Cash Per Share

2.26

2.38

11.233

Pretty Stable

Days Payables Outstanding

264

278

1.4 K

Slightly volatile

Current Ratio

1.43

1.5

4.6352

Pretty Stable

Capex Per Share

0.011

0.0116

0.8417

Very volatile

Interest Debt Per Share

2.27

1.7

3.0539

Slightly volatile

Debt To Assets

0.35

0.34

0.3532

Slightly volatile

Days Of Payables Outstanding

264

278

1.4 K

Slightly volatile

Quick Ratio

1.43

1.5

4.6073

Pretty Stable

Net Income Per E B T

0.77

0.9

0.9107

Slightly volatile

Cash Ratio

2.26

1.42

2.2612

Slightly volatile

Free Cash Flow Operating Cash Flow Ratio

1.17

1.15

1.0744

Pretty Stable

Debt Ratio

0.35

0.34

0.3532

Slightly volatile

PolyPid Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

18.5 M

20.7 M

24.4 M

Slightly volatile

Enterprise Value

20.4 M

13.7 M

28.1 M

Slightly volatile

PolyPid Fundamental Market Drivers

PolyPid Upcoming Events

	14th of February 2024 Upcoming Quarterly Report	View
	8th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	14th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

About PolyPid Financial Statements

PolyPid stakeholders use historical fundamental indicators, such as PolyPid's revenue or net income, to determine how well the company is positioned to perform in the future. Although PolyPid investors may analyze each financial statement separately, they are all interrelated. For example, changes in PolyPid's assets and liabilities are reflected in the revenues and expenses on PolyPid's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PolyPid. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Current Deferred Revenue	2.9 M	3.1 M
Cost Of Revenue	1.9 M	1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

WD	Walker Dunlop
GM	General Motors
GM	General Motors

When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:

How To Invest In PolyPid

Details

Is PolyPid Stock a good investment?

Details

What is PolyPid's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of PolyPid Correlation against competitors.

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Will Biotechnology sector continue expanding? Could PolyPid diversify its offerings? Factors like these will boost the valuation of PolyPid. Anticipated expansion of PolyPid directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PolyPid data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Earnings Share

(2.81)

Return On Assets

(0.88)

Return On Equity

(3.91)

The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

It's important to distinguish between PolyPid's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PolyPid should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, PolyPid's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

PolyPid Financial Statements From 2010 to 2026

PolyPid Balance Sheet

PolyPid Income Statement

PolyPid Cash Flow Statement

Financial Ratios

PolyPid Valuation Data

PolyPid Fundamental Market Drivers

PolyPid Upcoming Events

About PolyPid Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY